Here we extend these findings by showing in a large collection of ER+ breast tumors that gene expression profiles, as well as proliferation status, remain remarkably similar despite intervening time and treatment with both hormonal and chemotherapy regimens. This evidence concerns the gene ESR1 and breast neoplasm.